Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | PF-06263507 |
Synonyms | |
Therapy Description |
PF-06263507 is an antibody conjugate comprising an antibody that targets 5T4 conjugated to the microtubule agent, monomethylauristatin F, which may result in cell death and inhibition of tumor growth (PMID: 23223830, PMID: 28070718). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
PF-06263507 | PF06263507|PF 06263507|A1mcMMAF | PF-06263507 is an antibody conjugate comprising an antibody that targets 5T4 conjugated to the microtubule agent, monomethylauristatin F, which may result in cell death and inhibition of tumor growth (PMID: 23223830, PMID: 28070718). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|